Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Figure out How to Pick the Right Dental specialist for Your Dental Inserts - 2The cheap health insurance promoted by Trump officials has this catch
- 3Rights groups condemn Israel Police decision to ban Sudan Genocide protests nationwide
- 4Vote in favor of your #1 Kind of Cap
- 5Common ADHD medication prescribed in childhood may protect against risk of psychosis
- Style Narratives: A Survey of \Patterns and Styles Assessed\ Design
- What happened in 'Wicked' part 1 and will there be a 3rd movie? Recap and what Ariana Grande, Jon M. Chu have said about a sequel.
- Iranian-linked drone attack kills Kurdish couple in northern Iraq
- Former GLP-1 users regain lost weight after about 18 months, study says
- NASA astronauts take new moonsuit for a swim | Space photo of the day for Nov. 28, 2025
- A Russian fighting for Ukraine conned the Kremlin out of $500,000 by faking his own death
- Child influencers helped power a booming industry. It's time for a reckoning.
- How to watch 'A Charlie Brown Christmas' for free in 2025
- Aspect Biosystems receives funding for cellular medicine project
